nodes	percent_of_prediction	percent_of_DWPC	metapath
Dorzolamide—CYP2C9—Ifosfamide—testicular cancer	0.00365	0.352	CbGbCtD
Dorzolamide—CYP3A4—Ifosfamide—testicular cancer	0.00212	0.204	CbGbCtD
Dorzolamide—CYP2C9—Cisplatin—testicular cancer	0.00177	0.171	CbGbCtD
Dorzolamide—Body temperature increased—Ifosfamide—testicular cancer	0.00149	0.0015	CcSEcCtD
Dorzolamide—Anaphylactic shock—Etoposide—testicular cancer	0.00149	0.0015	CcSEcCtD
Dorzolamide—Mood swings—Doxorubicin—testicular cancer	0.00148	0.0015	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00148	0.00149	CcSEcCtD
Dorzolamide—Asthenia—Dactinomycin—testicular cancer	0.00147	0.00149	CcSEcCtD
Dorzolamide—Influenza—Epirubicin—testicular cancer	0.00146	0.00148	CcSEcCtD
Dorzolamide—Dysuria—Methotrexate—testicular cancer	0.00146	0.00148	CcSEcCtD
Dorzolamide—Paraesthesia—Cisplatin—testicular cancer	0.00146	0.00147	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Methotrexate—testicular cancer	0.00145	0.00147	CcSEcCtD
Dorzolamide—Dyspnoea—Cisplatin—testicular cancer	0.00145	0.00146	CcSEcCtD
Dorzolamide—Erectile dysfunction—Methotrexate—testicular cancer	0.00144	0.00146	CcSEcCtD
Dorzolamide—Hyperhidrosis—Etoposide—testicular cancer	0.00144	0.00145	CcSEcCtD
Dorzolamide—Angina pectoris—Epirubicin—testicular cancer	0.00143	0.00144	CcSEcCtD
Dorzolamide—Anorexia—Etoposide—testicular cancer	0.00142	0.00143	CcSEcCtD
Dorzolamide—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.00141	0.00143	CcSEcCtD
Dorzolamide—Decreased appetite—Cisplatin—testicular cancer	0.00141	0.00142	CcSEcCtD
Dorzolamide—Bronchitis—Epirubicin—testicular cancer	0.00141	0.00142	CcSEcCtD
Dorzolamide—Diarrhoea—Dactinomycin—testicular cancer	0.0014	0.00142	CcSEcCtD
Dorzolamide—Vomiting—Bleomycin—testicular cancer	0.0014	0.00141	CcSEcCtD
Dorzolamide—Depression—Methotrexate—testicular cancer	0.00139	0.00141	CcSEcCtD
Dorzolamide—Hypotension—Etoposide—testicular cancer	0.00139	0.0014	CcSEcCtD
Dorzolamide—Rash—Bleomycin—testicular cancer	0.00139	0.0014	CcSEcCtD
Dorzolamide—Pain—Cisplatin—testicular cancer	0.00139	0.0014	CcSEcCtD
Dorzolamide—Dermatitis—Bleomycin—testicular cancer	0.00139	0.0014	CcSEcCtD
Dorzolamide—Hypersensitivity—Ifosfamide—testicular cancer	0.00139	0.0014	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.00138	0.0014	CcSEcCtD
Dorzolamide—Dysuria—Epirubicin—testicular cancer	0.00137	0.00138	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Epirubicin—testicular cancer	0.00136	0.00137	CcSEcCtD
Dorzolamide—Conjunctivitis—Methotrexate—testicular cancer	0.00136	0.00137	CcSEcCtD
Dorzolamide—Influenza—Doxorubicin—testicular cancer	0.00135	0.00137	CcSEcCtD
Dorzolamide—Asthenia—Ifosfamide—testicular cancer	0.00135	0.00136	CcSEcCtD
Dorzolamide—Sweating—Methotrexate—testicular cancer	0.00134	0.00135	CcSEcCtD
Dorzolamide—Feeling abnormal—Cisplatin—testicular cancer	0.00134	0.00135	CcSEcCtD
Dorzolamide—Paraesthesia—Etoposide—testicular cancer	0.00133	0.00135	CcSEcCtD
Dorzolamide—Pruritus—Ifosfamide—testicular cancer	0.00133	0.00134	CcSEcCtD
Dorzolamide—Weight decreased—Epirubicin—testicular cancer	0.00132	0.00134	CcSEcCtD
Dorzolamide—Dyspnoea—Etoposide—testicular cancer	0.00132	0.00134	CcSEcCtD
Dorzolamide—Hyperglycaemia—Epirubicin—testicular cancer	0.00132	0.00133	CcSEcCtD
Dorzolamide—Somnolence—Etoposide—testicular cancer	0.00132	0.00133	CcSEcCtD
Dorzolamide—Angina pectoris—Doxorubicin—testicular cancer	0.00132	0.00133	CcSEcCtD
Dorzolamide—Epistaxis—Methotrexate—testicular cancer	0.00132	0.00133	CcSEcCtD
Dorzolamide—Nausea—Bleomycin—testicular cancer	0.00131	0.00132	CcSEcCtD
Dorzolamide—Vomiting—Dactinomycin—testicular cancer	0.0013	0.00132	CcSEcCtD
Dorzolamide—Bronchitis—Doxorubicin—testicular cancer	0.0013	0.00132	CcSEcCtD
Dorzolamide—Agranulocytosis—Methotrexate—testicular cancer	0.0013	0.00132	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.00129	0.00131	CcSEcCtD
Dorzolamide—Rash—Dactinomycin—testicular cancer	0.00129	0.00131	CcSEcCtD
Dorzolamide—Decreased appetite—Etoposide—testicular cancer	0.00129	0.0013	CcSEcCtD
Dorzolamide—Diarrhoea—Ifosfamide—testicular cancer	0.00129	0.0013	CcSEcCtD
Dorzolamide—Body temperature increased—Cisplatin—testicular cancer	0.00128	0.0013	CcSEcCtD
Dorzolamide—Fatigue—Etoposide—testicular cancer	0.00128	0.00129	CcSEcCtD
Dorzolamide—Pain—Etoposide—testicular cancer	0.00127	0.00128	CcSEcCtD
Dorzolamide—Conjunctivitis—Epirubicin—testicular cancer	0.00127	0.00128	CcSEcCtD
Dorzolamide—Urinary tract infection—Epirubicin—testicular cancer	0.00127	0.00128	CcSEcCtD
Dorzolamide—Dysuria—Doxorubicin—testicular cancer	0.00127	0.00128	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.00126	0.00127	CcSEcCtD
Dorzolamide—Sweating—Epirubicin—testicular cancer	0.00125	0.00126	CcSEcCtD
Dorzolamide—Dizziness—Ifosfamide—testicular cancer	0.00124	0.00126	CcSEcCtD
Dorzolamide—Pharyngitis—Methotrexate—testicular cancer	0.00124	0.00126	CcSEcCtD
Dorzolamide—Epistaxis—Epirubicin—testicular cancer	0.00123	0.00124	CcSEcCtD
Dorzolamide—Weight decreased—Doxorubicin—testicular cancer	0.00123	0.00124	CcSEcCtD
Dorzolamide—Sinusitis—Epirubicin—testicular cancer	0.00122	0.00124	CcSEcCtD
Dorzolamide—Feeling abnormal—Etoposide—testicular cancer	0.00122	0.00124	CcSEcCtD
Dorzolamide—Hyperglycaemia—Doxorubicin—testicular cancer	0.00122	0.00123	CcSEcCtD
Dorzolamide—Nausea—Dactinomycin—testicular cancer	0.00122	0.00123	CcSEcCtD
Dorzolamide—Agranulocytosis—Epirubicin—testicular cancer	0.00122	0.00123	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Etoposide—testicular cancer	0.00121	0.00123	CcSEcCtD
Dorzolamide—Visual impairment—Methotrexate—testicular cancer	0.00121	0.00122	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.0012	0.00121	CcSEcCtD
Dorzolamide—Vomiting—Ifosfamide—testicular cancer	0.0012	0.00121	CcSEcCtD
Dorzolamide—Hypersensitivity—Cisplatin—testicular cancer	0.00119	0.00121	CcSEcCtD
Dorzolamide—Bradycardia—Epirubicin—testicular cancer	0.00119	0.00121	CcSEcCtD
Dorzolamide—Rash—Ifosfamide—testicular cancer	0.00119	0.0012	CcSEcCtD
Dorzolamide—Dermatitis—Ifosfamide—testicular cancer	0.00118	0.0012	CcSEcCtD
Dorzolamide—Erythema multiforme—Methotrexate—testicular cancer	0.00118	0.0012	CcSEcCtD
Dorzolamide—Urticaria—Etoposide—testicular cancer	0.00118	0.00119	CcSEcCtD
Dorzolamide—Abdominal pain—Etoposide—testicular cancer	0.00117	0.00119	CcSEcCtD
Dorzolamide—Body temperature increased—Etoposide—testicular cancer	0.00117	0.00119	CcSEcCtD
Dorzolamide—Urinary tract infection—Doxorubicin—testicular cancer	0.00117	0.00119	CcSEcCtD
Dorzolamide—Conjunctivitis—Doxorubicin—testicular cancer	0.00117	0.00119	CcSEcCtD
Dorzolamide—Tinnitus—Methotrexate—testicular cancer	0.00117	0.00118	CcSEcCtD
Dorzolamide—Asthenia—Cisplatin—testicular cancer	0.00116	0.00118	CcSEcCtD
Dorzolamide—Pharyngitis—Epirubicin—testicular cancer	0.00116	0.00118	CcSEcCtD
Dorzolamide—Sweating—Doxorubicin—testicular cancer	0.00116	0.00117	CcSEcCtD
Dorzolamide—Epistaxis—Doxorubicin—testicular cancer	0.00114	0.00115	CcSEcCtD
Dorzolamide—Sinusitis—Doxorubicin—testicular cancer	0.00113	0.00115	CcSEcCtD
Dorzolamide—Visual impairment—Epirubicin—testicular cancer	0.00113	0.00114	CcSEcCtD
Dorzolamide—Agranulocytosis—Doxorubicin—testicular cancer	0.00113	0.00114	CcSEcCtD
Dorzolamide—CYP3A4—Vinblastine—testicular cancer	0.00113	0.108	CbGbCtD
Dorzolamide—Nausea—Ifosfamide—testicular cancer	0.00112	0.00113	CcSEcCtD
Dorzolamide—Diarrhoea—Cisplatin—testicular cancer	0.00111	0.00112	CcSEcCtD
Dorzolamide—Erythema multiforme—Epirubicin—testicular cancer	0.00111	0.00112	CcSEcCtD
Dorzolamide—Alopecia—Methotrexate—testicular cancer	0.00111	0.00112	CcSEcCtD
Dorzolamide—Bradycardia—Doxorubicin—testicular cancer	0.0011	0.00112	CcSEcCtD
Dorzolamide—Hypersensitivity—Etoposide—testicular cancer	0.00109	0.00111	CcSEcCtD
Dorzolamide—Tinnitus—Epirubicin—testicular cancer	0.00109	0.0011	CcSEcCtD
Dorzolamide—Erythema—Methotrexate—testicular cancer	0.00109	0.0011	CcSEcCtD
Dorzolamide—Pharyngitis—Doxorubicin—testicular cancer	0.00108	0.00109	CcSEcCtD
Dorzolamide—Dysgeusia—Methotrexate—testicular cancer	0.00107	0.00108	CcSEcCtD
Dorzolamide—Asthenia—Etoposide—testicular cancer	0.00107	0.00108	CcSEcCtD
Dorzolamide—Back pain—Methotrexate—testicular cancer	0.00105	0.00107	CcSEcCtD
Dorzolamide—Pruritus—Etoposide—testicular cancer	0.00105	0.00106	CcSEcCtD
Dorzolamide—Arrhythmia—Epirubicin—testicular cancer	0.00105	0.00106	CcSEcCtD
Dorzolamide—Visual impairment—Doxorubicin—testicular cancer	0.00104	0.00106	CcSEcCtD
Dorzolamide—Alopecia—Epirubicin—testicular cancer	0.00104	0.00105	CcSEcCtD
Dorzolamide—Vomiting—Cisplatin—testicular cancer	0.00103	0.00104	CcSEcCtD
Dorzolamide—Vision blurred—Methotrexate—testicular cancer	0.00103	0.00104	CcSEcCtD
Dorzolamide—Erythema multiforme—Doxorubicin—testicular cancer	0.00103	0.00104	CcSEcCtD
Dorzolamide—Rash—Cisplatin—testicular cancer	0.00102	0.00103	CcSEcCtD
Dorzolamide—Dermatitis—Cisplatin—testicular cancer	0.00102	0.00103	CcSEcCtD
Dorzolamide—Erythema—Epirubicin—testicular cancer	0.00102	0.00103	CcSEcCtD
Dorzolamide—Diarrhoea—Etoposide—testicular cancer	0.00102	0.00103	CcSEcCtD
Dorzolamide—CYP3A4—Etoposide—testicular cancer	0.00101	0.0977	CbGbCtD
Dorzolamide—Tinnitus—Doxorubicin—testicular cancer	0.00101	0.00102	CcSEcCtD
Dorzolamide—Tension—Epirubicin—testicular cancer	0.001	0.00101	CcSEcCtD
Dorzolamide—Dysgeusia—Epirubicin—testicular cancer	0.000999	0.00101	CcSEcCtD
Dorzolamide—Nervousness—Epirubicin—testicular cancer	0.000991	0.001	CcSEcCtD
Dorzolamide—Back pain—Epirubicin—testicular cancer	0.000987	0.000997	CcSEcCtD
Dorzolamide—Dizziness—Etoposide—testicular cancer	0.000982	0.000992	CcSEcCtD
Dorzolamide—Vertigo—Methotrexate—testicular cancer	0.000979	0.00099	CcSEcCtD
Dorzolamide—Arrhythmia—Doxorubicin—testicular cancer	0.000969	0.000979	CcSEcCtD
Dorzolamide—Nausea—Cisplatin—testicular cancer	0.000963	0.000973	CcSEcCtD
Dorzolamide—Vision blurred—Epirubicin—testicular cancer	0.000961	0.000971	CcSEcCtD
Dorzolamide—Alopecia—Doxorubicin—testicular cancer	0.000958	0.000968	CcSEcCtD
Dorzolamide—Cough—Methotrexate—testicular cancer	0.000951	0.000961	CcSEcCtD
Dorzolamide—Vomiting—Etoposide—testicular cancer	0.000944	0.000954	CcSEcCtD
Dorzolamide—Erythema—Doxorubicin—testicular cancer	0.000944	0.000954	CcSEcCtD
Dorzolamide—Rash—Etoposide—testicular cancer	0.000936	0.000946	CcSEcCtD
Dorzolamide—Dermatitis—Etoposide—testicular cancer	0.000936	0.000945	CcSEcCtD
Dorzolamide—Headache—Etoposide—testicular cancer	0.00093	0.00094	CcSEcCtD
Dorzolamide—Arthralgia—Methotrexate—testicular cancer	0.000928	0.000938	CcSEcCtD
Dorzolamide—Chest pain—Methotrexate—testicular cancer	0.000928	0.000938	CcSEcCtD
Dorzolamide—Tension—Doxorubicin—testicular cancer	0.000926	0.000936	CcSEcCtD
Dorzolamide—Dysgeusia—Doxorubicin—testicular cancer	0.000924	0.000934	CcSEcCtD
Dorzolamide—Discomfort—Methotrexate—testicular cancer	0.000917	0.000927	CcSEcCtD
Dorzolamide—Nervousness—Doxorubicin—testicular cancer	0.000917	0.000926	CcSEcCtD
Dorzolamide—Vertigo—Epirubicin—testicular cancer	0.000916	0.000926	CcSEcCtD
Dorzolamide—Syncope—Epirubicin—testicular cancer	0.000915	0.000924	CcSEcCtD
Dorzolamide—Back pain—Doxorubicin—testicular cancer	0.000913	0.000923	CcSEcCtD
Dorzolamide—Palpitations—Epirubicin—testicular cancer	0.000901	0.000911	CcSEcCtD
Dorzolamide—Confusional state—Methotrexate—testicular cancer	0.000897	0.000906	CcSEcCtD
Dorzolamide—Loss of consciousness—Epirubicin—testicular cancer	0.000897	0.000906	CcSEcCtD
Dorzolamide—Cough—Epirubicin—testicular cancer	0.00089	0.000899	CcSEcCtD
Dorzolamide—Anaphylactic shock—Methotrexate—testicular cancer	0.00089	0.000899	CcSEcCtD
Dorzolamide—Vision blurred—Doxorubicin—testicular cancer	0.00089	0.000899	CcSEcCtD
Dorzolamide—Nausea—Etoposide—testicular cancer	0.000882	0.000891	CcSEcCtD
Dorzolamide—Hypertension—Epirubicin—testicular cancer	0.000881	0.00089	CcSEcCtD
Dorzolamide—Arthralgia—Epirubicin—testicular cancer	0.000868	0.000878	CcSEcCtD
Dorzolamide—Chest pain—Epirubicin—testicular cancer	0.000868	0.000878	CcSEcCtD
Dorzolamide—Anxiety—Epirubicin—testicular cancer	0.000865	0.000875	CcSEcCtD
Dorzolamide—Hyperhidrosis—Methotrexate—testicular cancer	0.00086	0.000869	CcSEcCtD
Dorzolamide—Discomfort—Epirubicin—testicular cancer	0.000858	0.000867	CcSEcCtD
Dorzolamide—Dry mouth—Epirubicin—testicular cancer	0.000849	0.000858	CcSEcCtD
Dorzolamide—Vertigo—Doxorubicin—testicular cancer	0.000848	0.000857	CcSEcCtD
Dorzolamide—Anorexia—Methotrexate—testicular cancer	0.000848	0.000857	CcSEcCtD
Dorzolamide—Syncope—Doxorubicin—testicular cancer	0.000846	0.000855	CcSEcCtD
Dorzolamide—Confusional state—Epirubicin—testicular cancer	0.000839	0.000848	CcSEcCtD
Dorzolamide—Palpitations—Doxorubicin—testicular cancer	0.000834	0.000843	CcSEcCtD
Dorzolamide—Anaphylactic shock—Epirubicin—testicular cancer	0.000833	0.000841	CcSEcCtD
Dorzolamide—Oedema—Epirubicin—testicular cancer	0.000833	0.000841	CcSEcCtD
Dorzolamide—Hypotension—Methotrexate—testicular cancer	0.000831	0.00084	CcSEcCtD
Dorzolamide—Loss of consciousness—Doxorubicin—testicular cancer	0.00083	0.000838	CcSEcCtD
Dorzolamide—Cough—Doxorubicin—testicular cancer	0.000824	0.000832	CcSEcCtD
Dorzolamide—Shock—Epirubicin—testicular cancer	0.000819	0.000828	CcSEcCtD
Dorzolamide—Hypertension—Doxorubicin—testicular cancer	0.000815	0.000823	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000811	0.000819	CcSEcCtD
Dorzolamide—Hyperhidrosis—Epirubicin—testicular cancer	0.000805	0.000813	CcSEcCtD
Dorzolamide—Insomnia—Methotrexate—testicular cancer	0.000805	0.000813	CcSEcCtD
Dorzolamide—Arthralgia—Doxorubicin—testicular cancer	0.000804	0.000812	CcSEcCtD
Dorzolamide—Chest pain—Doxorubicin—testicular cancer	0.000804	0.000812	CcSEcCtD
Dorzolamide—Anxiety—Doxorubicin—testicular cancer	0.000801	0.000809	CcSEcCtD
Dorzolamide—Paraesthesia—Methotrexate—testicular cancer	0.000799	0.000807	CcSEcCtD
Dorzolamide—Discomfort—Doxorubicin—testicular cancer	0.000794	0.000802	CcSEcCtD
Dorzolamide—Anorexia—Epirubicin—testicular cancer	0.000794	0.000802	CcSEcCtD
Dorzolamide—Dyspnoea—Methotrexate—testicular cancer	0.000793	0.000801	CcSEcCtD
Dorzolamide—Somnolence—Methotrexate—testicular cancer	0.000791	0.000799	CcSEcCtD
Dorzolamide—Dry mouth—Doxorubicin—testicular cancer	0.000786	0.000794	CcSEcCtD
Dorzolamide—Dyspepsia—Methotrexate—testicular cancer	0.000783	0.000791	CcSEcCtD
Dorzolamide—Hypotension—Epirubicin—testicular cancer	0.000778	0.000786	CcSEcCtD
Dorzolamide—Confusional state—Doxorubicin—testicular cancer	0.000777	0.000785	CcSEcCtD
Dorzolamide—Decreased appetite—Methotrexate—testicular cancer	0.000773	0.000781	CcSEcCtD
Dorzolamide—Anaphylactic shock—Doxorubicin—testicular cancer	0.00077	0.000778	CcSEcCtD
Dorzolamide—Oedema—Doxorubicin—testicular cancer	0.00077	0.000778	CcSEcCtD
Dorzolamide—Fatigue—Methotrexate—testicular cancer	0.000767	0.000775	CcSEcCtD
Dorzolamide—Pain—Methotrexate—testicular cancer	0.000761	0.000769	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000759	0.000766	CcSEcCtD
Dorzolamide—Shock—Doxorubicin—testicular cancer	0.000758	0.000766	CcSEcCtD
Dorzolamide—Insomnia—Epirubicin—testicular cancer	0.000753	0.000761	CcSEcCtD
Dorzolamide—Paraesthesia—Epirubicin—testicular cancer	0.000748	0.000755	CcSEcCtD
Dorzolamide—Hyperhidrosis—Doxorubicin—testicular cancer	0.000745	0.000753	CcSEcCtD
Dorzolamide—Dyspnoea—Epirubicin—testicular cancer	0.000742	0.00075	CcSEcCtD
Dorzolamide—Somnolence—Epirubicin—testicular cancer	0.00074	0.000748	CcSEcCtD
Dorzolamide—Anorexia—Doxorubicin—testicular cancer	0.000734	0.000742	CcSEcCtD
Dorzolamide—Feeling abnormal—Methotrexate—testicular cancer	0.000733	0.000741	CcSEcCtD
Dorzolamide—Dyspepsia—Epirubicin—testicular cancer	0.000733	0.000741	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Methotrexate—testicular cancer	0.000727	0.000735	CcSEcCtD
Dorzolamide—Decreased appetite—Epirubicin—testicular cancer	0.000724	0.000731	CcSEcCtD
Dorzolamide—Hypotension—Doxorubicin—testicular cancer	0.00072	0.000727	CcSEcCtD
Dorzolamide—Fatigue—Epirubicin—testicular cancer	0.000718	0.000725	CcSEcCtD
Dorzolamide—Pain—Epirubicin—testicular cancer	0.000712	0.000719	CcSEcCtD
Dorzolamide—Urticaria—Methotrexate—testicular cancer	0.000707	0.000714	CcSEcCtD
Dorzolamide—Body temperature increased—Methotrexate—testicular cancer	0.000703	0.000711	CcSEcCtD
Dorzolamide—Abdominal pain—Methotrexate—testicular cancer	0.000703	0.000711	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000702	0.000709	CcSEcCtD
Dorzolamide—Insomnia—Doxorubicin—testicular cancer	0.000697	0.000704	CcSEcCtD
Dorzolamide—Paraesthesia—Doxorubicin—testicular cancer	0.000692	0.000699	CcSEcCtD
Dorzolamide—CYP3A4—Doxorubicin—testicular cancer	0.000691	0.0666	CbGbCtD
Dorzolamide—Dyspnoea—Doxorubicin—testicular cancer	0.000687	0.000694	CcSEcCtD
Dorzolamide—Feeling abnormal—Epirubicin—testicular cancer	0.000686	0.000693	CcSEcCtD
Dorzolamide—Somnolence—Doxorubicin—testicular cancer	0.000685	0.000692	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Epirubicin—testicular cancer	0.000681	0.000688	CcSEcCtD
Dorzolamide—Dyspepsia—Doxorubicin—testicular cancer	0.000678	0.000685	CcSEcCtD
Dorzolamide—Decreased appetite—Doxorubicin—testicular cancer	0.00067	0.000677	CcSEcCtD
Dorzolamide—Fatigue—Doxorubicin—testicular cancer	0.000664	0.000671	CcSEcCtD
Dorzolamide—Urticaria—Epirubicin—testicular cancer	0.000661	0.000668	CcSEcCtD
Dorzolamide—Pain—Doxorubicin—testicular cancer	0.000659	0.000666	CcSEcCtD
Dorzolamide—Abdominal pain—Epirubicin—testicular cancer	0.000658	0.000665	CcSEcCtD
Dorzolamide—Body temperature increased—Epirubicin—testicular cancer	0.000658	0.000665	CcSEcCtD
Dorzolamide—Hypersensitivity—Methotrexate—testicular cancer	0.000655	0.000662	CcSEcCtD
Dorzolamide—Asthenia—Methotrexate—testicular cancer	0.000638	0.000645	CcSEcCtD
Dorzolamide—Feeling abnormal—Doxorubicin—testicular cancer	0.000635	0.000641	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00063	0.000637	CcSEcCtD
Dorzolamide—Pruritus—Methotrexate—testicular cancer	0.000629	0.000636	CcSEcCtD
Dorzolamide—Hypersensitivity—Epirubicin—testicular cancer	0.000613	0.00062	CcSEcCtD
Dorzolamide—Urticaria—Doxorubicin—testicular cancer	0.000612	0.000618	CcSEcCtD
Dorzolamide—Abdominal pain—Doxorubicin—testicular cancer	0.000609	0.000615	CcSEcCtD
Dorzolamide—Body temperature increased—Doxorubicin—testicular cancer	0.000609	0.000615	CcSEcCtD
Dorzolamide—Diarrhoea—Methotrexate—testicular cancer	0.000609	0.000615	CcSEcCtD
Dorzolamide—Asthenia—Epirubicin—testicular cancer	0.000597	0.000604	CcSEcCtD
Dorzolamide—Pruritus—Epirubicin—testicular cancer	0.000589	0.000595	CcSEcCtD
Dorzolamide—Dizziness—Methotrexate—testicular cancer	0.000588	0.000594	CcSEcCtD
Dorzolamide—Diarrhoea—Epirubicin—testicular cancer	0.00057	0.000576	CcSEcCtD
Dorzolamide—Hypersensitivity—Doxorubicin—testicular cancer	0.000568	0.000573	CcSEcCtD
Dorzolamide—Vomiting—Methotrexate—testicular cancer	0.000566	0.000572	CcSEcCtD
Dorzolamide—Rash—Methotrexate—testicular cancer	0.000561	0.000567	CcSEcCtD
Dorzolamide—Dermatitis—Methotrexate—testicular cancer	0.00056	0.000566	CcSEcCtD
Dorzolamide—Headache—Methotrexate—testicular cancer	0.000557	0.000563	CcSEcCtD
Dorzolamide—Asthenia—Doxorubicin—testicular cancer	0.000553	0.000558	CcSEcCtD
Dorzolamide—Dizziness—Epirubicin—testicular cancer	0.000551	0.000556	CcSEcCtD
Dorzolamide—Pruritus—Doxorubicin—testicular cancer	0.000545	0.000551	CcSEcCtD
Dorzolamide—Vomiting—Epirubicin—testicular cancer	0.000529	0.000535	CcSEcCtD
Dorzolamide—Nausea—Methotrexate—testicular cancer	0.000528	0.000534	CcSEcCtD
Dorzolamide—Diarrhoea—Doxorubicin—testicular cancer	0.000527	0.000533	CcSEcCtD
Dorzolamide—Rash—Epirubicin—testicular cancer	0.000525	0.00053	CcSEcCtD
Dorzolamide—Dermatitis—Epirubicin—testicular cancer	0.000524	0.00053	CcSEcCtD
Dorzolamide—Headache—Epirubicin—testicular cancer	0.000522	0.000527	CcSEcCtD
Dorzolamide—Dizziness—Doxorubicin—testicular cancer	0.000509	0.000515	CcSEcCtD
Dorzolamide—Nausea—Epirubicin—testicular cancer	0.000495	0.0005	CcSEcCtD
Dorzolamide—Vomiting—Doxorubicin—testicular cancer	0.00049	0.000495	CcSEcCtD
Dorzolamide—Rash—Doxorubicin—testicular cancer	0.000486	0.000491	CcSEcCtD
Dorzolamide—Dermatitis—Doxorubicin—testicular cancer	0.000485	0.00049	CcSEcCtD
Dorzolamide—Headache—Doxorubicin—testicular cancer	0.000483	0.000488	CcSEcCtD
Dorzolamide—Nausea—Doxorubicin—testicular cancer	0.000458	0.000462	CcSEcCtD
